BOSTON – Since 2011, new developments regarding hyperthyroidism treatment and the causes of thyrotoxicosis have prompted the American Thyroid Association (ATA) to update their hyperthyroidism guidelines.
In this video from ENDO 2016, Douglas Ross, MD, from Massachusetts General Hospital, discusses the new changes in the ATA 2016 guidelines, which include new recommendations for thyrotropin receptor antibody and radioactive iodine use.
Please login or register first to view this content.
Enjoying our content?
Thanks for visiting Endocrinology Advisor. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Endocrinology Advisor. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Please login or register first to view this content.